Nemis
NEMIS Technologies is a biotechnology company which develops diagnostic kits and solutions for accelerated microbiological.
Total raised
€11M
€10,532,230
Funding rounds
2
Investors
0
distinct backers
Active since
2020-03
latest 2022-02
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood40
base rate 44% for Series A
- ▼ Overdue vs cohort gap
- ▲ Up-round momentum
Exit likelihood13
base rate 12% (2+ rounds)
- ▲ 8y since founding
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-02-05 | Series A | €7.3M | — | View deal → |
| 2020-03-16 | Series B | €3.2M | — | View deal → |
Related news
- Nemis Technologies closes CHF7.75 million Series A funding roundstartupticker.ch · 2022-02
- startupticker.ch
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy